. U.S. to resume Johnson & Johnson COVID-19 vaccinations « JO LEE MAGAZINE

PBS – U.S. health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson’s single-dose shot on Friday, after scientific advisers decided its benefits outweigh a rare risk of blood clot.

The government uncovered 15 vaccine recipients who developed a highly unusual kind of blood clot, out of nearly 8 million people given the J&J shot. All were women; three died, and seven remain hospitalized.

But ultimately, the FDA and CDC decided that J&J’s one-and-done vaccine is critical to fight the pandemic.

Continue reading at PBS News Hour.

World on the Run | Jo Lee Magazine

Comments are closed.